Research Alliance Corp III (RACC) stock
RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.01−0.06 (-0.60%)
Close on Nov 19, 2026Market cap $91.08MP/E –Yield –
Research Alliance Corp III net income
Net income is the profit left for shareholders after every expense, interest and tax.
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.95M | – |
| Q2 FY2026 | Jun 30, 2026 | $54.05K | – |
See a number that looks wrong?